AdvaMedDx Announces Newly Elected Board Members

You are here

AdvaMedDx Announces Newly Elected Board Members

April 2, 2013

WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that is focused solely on opportunities and challenges facing companies that develop and manufacture medical diagnostic technologies, today announced the recent election of several new members to its board of directors.

The new members of the AdvaMedDx board are:

  • Gregory Arnsdorff, vice president of Abbott Laboratories and president of Abbott Point of Care
  • Nefertiti Greene, vice president, U.S. Diabetes Care at Bayer HealthCare Diabetes Care
  • Brian Miller, managing partner at Linden Capital Partners
  • Rick Brajer, president and CEO of LipoScience

“We’re pleased to welcome the newest additions to our board of directors. I look forward to working closely with them and the other members of the board to continue to drive the mission of AdvaMedDx, which is to partner with stakeholders from across the health care community to improve public health through the appropriate use of innovative diagnostic technologies for early detection and prevention of disease,” said Vincent Forlenza, BD Chairman, CEO and president and AdvaMedDx board chairman.

“Our board of directors is strengthened with the newest additions to our leadership,” said Andrew Fish, AdvaMedDx executive director. “The board members’ keen insights and strategic direction are invaluable as we continue to grow the organization and expand our partnerships with patient advocates and other key stakeholders.”

# # #

AdvaMedDx member companies produce innovative, safe and effective in vitro diagnostic tests that facilitate evidence-based medicine, improve quality of patient care, promote wellness, enable early detection of disease and reduce overall health care costs. Functioning as an association within AdvaMed, AdvaMedDx is dedicated to the issues facing in vitro diagnostic companies both in the United States and abroad.

For more information, please contact: Wanda Moebius @ (202) 434-7240